Cancer

November 18, 2021

Team receives Association of Community Cancer Centers Innovator Award

A team of Vanderbilt employees have received and award for implementing a streamlined follow-up protocol for patients who may not know they have cancer.

By Tom Wilemon
November 18, 2021

Chic Awearness gala to support ovarian cancer research set for Dec. 6

Chic Awearness, a fashion show and fundraiser for ovarian cancer research, returns as an in-person event from 6:30 p.m. to 8:30 p.m. on Monday, Dec. 6.

By Tom Wilemon
Child ambassador Grace Hamilton, 13, rides the Zamboni at the Nashville Predators Hockey Fights Cancer game Nov. 13.
November 17, 2021

Hockey Fights Cancer comes through for Children’s Hospital

The Nashville Predators hockey team continued its longtime support of Monroe Carell Jr. Children’s Hospital at Vanderbilt with this week’s Hockey Fights Cancer game.

By Christina Echegaray
Ayaka Sugiura and Jeff Rathmell, PhD, are studying a metabolic enzyme involved in T cell function that may offer a new target for anti-inflammatory therapeutics.
November 11, 2021

CRISPR screen identifies new anti-inflammatory drug target

A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

By Leigh MacMillan
November 4, 2021

Koerkenmeier named VICC associate nursing officer

By Tom Wilemon
November 1, 2021

Breast cancer survivors: eat nuts

Breast cancer survivors who reported eating nuts regularly had 50% reduced risk of breast cancer recurrence, metastasis or mortality, Vanderbilt epidemiologists found in Shanghai Breast Cancer Survival Study.

By Leigh MacMillan
October 28, 2021

V Foundation to support study of pediatric soft tissue sarcoma

By Doug Campbell
October 28, 2021

VICC’s Mayer departing to take new role with AstraZeneca

Ingrid Mayer, MD, MSCI, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.
By Tom Wilemon
October 21, 2021

New robot enhances accuracy of head, neck cancer surgeries

By Emily Stembridge
October 21, 2021

Study to evaluate how environment impacts cancer risk

Vanderbilt-Ingram Cancer Center is leading an ambitious project to assess the impact of environmental exposures on cancer risk for people living in Southern states.
By Tom Wilemon
October 19, 2021

Combo therapy slows prostate cancer

A new combination treatment showed promise in slowing the growth of castration-resistant prostate cancer in animal models, Vanderbilt researchers discovered.
By Leigh MacMillan
October 14, 2021

New marker for metaplasia

A protein that transports water, called aquaporin 5, is expressed by cells undergoing changes that may increase risk for gastric cancer development, Vanderbilt researchers discovered.
By Bill Snyder
October 14, 2021

Photoimmunotherapy offered in clinical trial for recurrent head and neck cancer

Vanderbilt-Ingram Cancer Center is recruiting patients for a clinical trial using photoimmunotherapy for recurrent head and neck cancer.
By Tom Wilemon